Stock Comparison
ABT vs GEHC
Abbott Laboratories and GE HealthCare Technologies Inc. side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$163.94B
$29.91B
P/E (TTM)
26.4
15.8
Forward P/E
17.2
13.4
Price/Sales
3.6
1.4
Price/Book
3.2
2.8
EV/EBITDA
16.1
10.6
Dividend Yield
2.62%
0.22%
Profitability
Net Margin
13.90%
9.10%
Operating Margin
13.50%
11.10%
Return on Equity
12.30%
19.50%
Return on Assets
5.59%
5.17%
Growth (YoY)
Revenue Growth
7.80%
7.40%
Earnings Growth
-19.70%
-30.90%
Price & Risk
Beta
0.6
0.9
52-Week High
$135.34
$89.69
52-Week Low
$81.97
$58.75
Analyst Target
$116.54
$79.74
Compare ABT and GEHC your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.